Planning controlled clinical trials on the basis of descriptive data analysis

Area of Science:

• Biostatistics
• Clinical Trial Design
• Statistical Inference

Background:

• The issue of multiplicity in inferential statements is a growing concern in controlled clinical trials.
• Existing methods often struggle to balance exploratory and confirmatory analyses when dealing with multiple variables or time points.

Purpose of the Study:

• To apply the Descriptive Data Analysis (DDA) framework to the planning of controlled clinical trials facing multiplicity challenges.
• To provide investigators with practical tools for drawing conclusions from complex trial data.

Main Methods:

• Utilizing a non-Bayesian Descriptive Data Analysis (DDA) planning concept.
• Integrating pre-trial medical expertise with descriptive inferential statements (confidence intervals, test results) at nominal significance levels.
• Developing methods for confirmatory statements on individual and partially global null hypotheses.

Main Results:

• The DDA planning concept offers a structured approach to manage multiplicity in clinical trials.
• It enables the combination of prior medical knowledge with statistical evidence for decision-making.
• The framework supports drawing conclusions across multiple variables, time points, and subject groups.

Conclusions:

• Descriptive Data Analysis (DDA) provides a valuable methodology for planning controlled clinical trials with multiplicity issues.
• It enhances the ability to draw reliable conclusions by bridging prior knowledge and data analysis.
• DDA facilitates both descriptive and confirmatory inferential statements in complex trial designs.